109 related articles for article (PubMed ID: 8620441)
1. Quantitation of the nucleophosmin/B23-translocation using imaging analysis.
Chan PK; Qi Y; Amley J; Koller CA
Cancer Lett; 1996 Feb; 100(1-2):191-7. PubMed ID: 8620441
[TBL] [Abstract][Full Text] [Related]
2. A study of correlation between NPM-translocation and apoptosis in cells induced by daunomycin.
Chan PK; Chan FY
Biochem Pharmacol; 1999 Jun; 57(11):1265-73. PubMed ID: 10230770
[TBL] [Abstract][Full Text] [Related]
3. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism).
Chan PK
Exp Cell Res; 1992 Nov; 203(1):174-81. PubMed ID: 1426041
[TBL] [Abstract][Full Text] [Related]
4. Studies of actinomycin D induced B23-translocation in P388D1 cells implanted in DBA/2 mice.
Finch RA; Chan PK
Oncology; 1992; 49(3):223-6. PubMed ID: 1495750
[TBL] [Abstract][Full Text] [Related]
5. Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.
Brodská B; Holoubek A; Otevřelová P; Kuželová K
J Cell Biochem; 2016 Jun; 117(6):1319-29. PubMed ID: 26505272
[TBL] [Abstract][Full Text] [Related]
6. Effects of cytotoxic drugs on translocation of nucleolar RNA helicase RH-II/Gu.
Perlaky L; Valdez BC; Busch H
Exp Cell Res; 1997 Sep; 235(2):413-20. PubMed ID: 9299166
[TBL] [Abstract][Full Text] [Related]
7. Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells.
Yung BY; Bor AM; Chan PK
Cancer Res; 1990 Sep; 50(18):5987-91. PubMed ID: 1697505
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal half of NPM dissociates from nucleoli of HeLa cells after anticancer drug treatments.
Chan PK; Bloom DA; Hoang TT
Biochem Biophys Res Commun; 1999 Oct; 264(1):305-9. PubMed ID: 10527882
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of nucleophosmin/B23 increases drug sensitivity of adriamycin-resistant Molt-4 leukemia cells through mdr-1 regulation and Akt/mTOR signaling.
Wang L; Chen B; Lin M; Cao Y; Chen Y; Chen X; Liu T; Hu J
Immunobiology; 2015 Mar; 220(3):331-40. PubMed ID: 25457413
[TBL] [Abstract][Full Text] [Related]
10. ATP depletion affects NPM translocation and exportation of rRNA from nuclei.
Finch RA; Chan PK
Biochem Biophys Res Commun; 1996 May; 222(2):553-8. PubMed ID: 8670243
[TBL] [Abstract][Full Text] [Related]
11. Translocation of nucleophosmin from nucleoli to nucleoplasm requires ATP.
Wu MH; Lam CY; Yung BY
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):987-92. PubMed ID: 7848301
[TBL] [Abstract][Full Text] [Related]
12. GTP gamma S restores nucleophosmin (NPM) localization to nucleoli of GTP-depleted HeLa cells.
Finch RA; Chang DC; Chan PK
Mol Cell Biochem; 1995 May; 146(2):171-8. PubMed ID: 7565647
[TBL] [Abstract][Full Text] [Related]
13. Nucleolar protein B23 translocation after deferoxamine treatment in a human leukemia cell line.
Yung BY; Yang YH; Bor AM
Int J Cancer; 1991 Jul; 48(5):779-84. PubMed ID: 2071236
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein B23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells.
Sweet P; Chan PK; Slater LM
Cancer Res; 1989 Feb; 49(3):677-80. PubMed ID: 2910487
[TBL] [Abstract][Full Text] [Related]
15. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
[TBL] [Abstract][Full Text] [Related]
16. Schedule-dependent effects of two consecutive, divided, low doses of actinomycin D on translocation of protein B23, inhibition of cell growth and RNA synthesis in HeLa cells.
Yung BY; Chang FJ; Bor AM; Lee ES
Int J Cancer; 1992 Sep; 52(2):317-22. PubMed ID: 1381705
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional relationships of toyocamycin on NPM-translocation.
Finch RA; Revankar GR; Chan PK
Anticancer Drug Des; 1997 Apr; 12(3):205-15. PubMed ID: 9154111
[TBL] [Abstract][Full Text] [Related]
18. Nucleolar localization of nucleophosmin/B23 requires GTP.
Finch RA; Revankar GR; Chan PK
J Biol Chem; 1993 Mar; 268(8):5823-7. PubMed ID: 8095498
[TBL] [Abstract][Full Text] [Related]
19. GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.
Kim JY; Cho YE; An YM; Kim SH; Lee YG; Park JH; Lee S
J Cell Mol Med; 2015 Jun; 19(6):1245-52. PubMed ID: 25818168
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of nucleophosmin induces S-phase arrest in HepG2 cells.
Wang QQ; Zhang ZY; Xiao JY; Yi C; Li LZ; Huang Y; Yun JP
Chin J Cancer; 2011 Dec; 30(12):853-60. PubMed ID: 22098949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
